Malta Captive Insurance: PCC and Cell Structures Explained

Start with the right distinction

A group treasurer may begin with a simple question: should we establish a captive, a PCC or an ICC? The better sequence is to separate three decisions. First, does the proposed business qualify as captive or affiliated insurance? Second, should the legal form be a standalone company, a PCC or an ICC? Third, what operating model will provide governance, substance, underwriting, claims, reporting and outsourced support? A captive PCC cell and a captive ICC cell are both possible combinations.

What counts as a Malta captive?

Under Malta’s Insurance Business (Captive Insurance Undertakings and Captive Reinsurance Undertakings) Regulations, a captive insurance undertaking is an authorised insurance undertaking owned by a qualifying financial or non-financial undertaking or group, whose purpose is to provide insurance cover exclusively for the risks of the undertaking, its group or relevant group undertakings. A captive reinsurer follows the same group-risk principle for reinsurance cover.

That definition describes the risk perimeter, not the corporate architecture. The same captive concept can sit in a standalone authorised company, a PCC cell or an incorporated ICC cell, provided the ownership, affiliated-risk restriction, business classes and authorisation position fit the applicable framework. Conversely, a PCC or ICC may be used for insurance business that is not captive where the relevant regulatory requirements are met.

Captives remain subject to the Insurance Business Act, regulations and Insurance Rules broadly as authorised insurers or reinsurers, subject to the modifications and disapplications in the captive regulations. The rules also allow an MFSA-approved insurance manager in the circumstances provided by the framework. Delegation may change who performs a function; it does not transfer the undertaking’s regulatory responsibility.

PCC mechanics: shared infrastructure, real segregation

A protected cell company is one legal entity comprising a non-cellular core and one or more cells. A protected cell has no separate legal identity, and one board retains ultimate responsibility for the PCC and its cells. Each cell must be distinctly designated, and counterparties should be told that they are dealing with a PCC and which cell is involved in the transaction.

Cellular assets and liabilities must be segregated from the core and from other cells. Cellular creditors generally have a claim first against the assets of the relevant cell and a right of secondary recourse to core assets once those cellular assets are exhausted. Assets attributable to one cell should not be used to meet another cell’s liabilities, but segregation is not the same as an absolute promise that core assets can never be reached.

The directors must keep cellular assets separately identifiable from non-cellular assets and from assets attributable to other cells. That requires disciplined accounting, banking, investment, policy, reinsurance and outsourcing arrangements. It also requires information that lets the board understand each programme’s exposure rather than treating shared administration as a substitute for cell-level oversight.

Does the PCC core itself write insurance?

Do not assume that the PCC core and every cell have the same permission to write insurance. The authorisation and approval documents determine which undertaking or cell may conduct which business, while the core may provide the non-cellular framework, assets and governance required by the structure. The actual liability map should therefore be built from the authorisation scope, cell approval, policy and reinsurance contracts, rather than from the word “core” alone.

PCC or ICC?

An ICC is legally different from a PCC. Each incorporated cell is a limited-liability company with separate legal personality, and the MFSA’s information note states that both the ICC and its incorporated cells require individual authorisation under the Insurance Business Act. That may suit a programme where counterparties, financing arrangements or internal risk policy require entity-level separation.

Separate personality does not eliminate every commercial exposure. Guarantees, letters of credit, parental support, policy wording, reinsurance, service agreements and other transaction documents can create obligations beyond the cell’s own balance sheet. An ICC therefore offers a different legal starting point, not an automatic answer to recourse, insolvency or group-support questions.

A PCC can make commercial sense where several programmes can use common infrastructure and the board can maintain clean cell-level records, controls and decision-making. A standalone captive may be cleaner where one group has sufficient scale and wants a dedicated balance sheet. An ICC may be justified where separate legal personality is worth the additional portfolio of companies, approvals, governance, accounts and capital analysis.

Can unrelated groups share one PCC?

A PCC can contain multiple cells, but that does not make every proposed combination commercially sensible or automatically acceptable. For each proposed programme, test the ownership and affiliated-risk perimeter, business classes, conflicts, asset and liability attribution, governance, outsourcing, reporting and the board’s ability to supervise the whole undertaking. The sources reviewed do not establish a blanket rule that permits or prohibits unrelated corporate groups from sharing one insurance PCC.

Who must be authorised or approved?

The insurance undertaking or PCC requires MFSA authorisation, and a new cell requires prior written approval. The MFSA’s current authorisations page provides separate routes for an undertaking, a reinsurer or captive, and the incorporation of cells. Malta Business Registry incorporation is therefore one step in the sequence; it does not authorise insurance activity or cell operations.

The approval file should address the proposed business model, ownership and controllers, fit-and-proper status, scheme of operations, governance, own funds, solvency, risk management, technical provisions, outsourcing and operational capability. The board remains ultimately responsible even where an insurance manager or other service provider performs delegated functions.

For cell committees, the MFSA’s July 9, 2026 circular changed the approval process with immediate effect. Cell committee members of captive cells of insurance undertaking PCCs, insurance broker PCCs and insurance manager PCCs are no longer subject to an MFSA fitness-and-properness assessment; only the chair is subject to the personal questionnaire process. The licence holder must still conduct due diligence and suitability assessments before appointment and throughout the engagement, keep evidence of those assessments and maintain its corporate profile.

A practical approval sequence

Begin by defining the group-risk perimeter, proposed policyholders, business classes and direct-insurance or reinsurance model. Then compare a standalone captive, captive PCC cell and captive ICC cell; map contractual recourse; assess capital and technical provisions; and design governance, substance, outsourcing, reporting, banking and investment arrangements. This is the point at which the structure should be tested against the group’s actual risk map, not merely against an incorporation timetable.

Prepare the MFSA submission, answer supervisory questions, obtain the required authorisation or approval, complete the corporate steps and then obtain written approval for each proposed cell before it begins insurance operations. The timing is not simply “incorporate first, license later”: the PCC regulations require competent-authority approval before a company is formed or converted as a cell company, and prior approval is required before a cell is created.

Do not build the board paper around one universal capital number. The applicable minimum capital, notional SCR or MCR treatment and fees depend on the business class, direct or reinsurance model, captive classification, applicable Solvency II rules and the MFSA’s assessment of the actual programme.

Recourse and non-recourse: the current position

The current position is conditional, not unresolved and not universal. MFSA’s 2024 amendments stated that a new Regulation 15A would allow a non-recourse clause to continue where a cell carries on affiliated insurance and holds eligible basic own funds covering its SCR, with that SCR not less than the MCR as if the cell were an authorised insurance or reinsurance undertaking. The affiliated-risk definition described in the circular focuses on risks originating from the sole cell-shareholder or undertakings in which that shareholder holds a participating interest.

The 2024 MFSA materials also addressed a ten-year transitional period for certain existing cells using the earlier non-recourse provision. That does not mean every existing cell qualifies, nor that a new cell can rely on non-recourse merely because it is described as captive. Confirm the operative consolidated regulation, the cell’s authorisation date, its business, own-funds position and approval conditions before relying on the protection.

For commercial planning, model both cases: the qualifying non-recourse position and the possibility that core assets, parental support or other contractual resources matter. “Pay-as-paid” wording or a non-recourse clause cannot substitute for checking the statutory position, policy terms, reinsurance chain, guarantees and the balance sheet available to meet obligations.

Run-off, transfer and insolvency

MFSA Chapter 17 addresses the transfer of cellular assets, cessation, servicing, run-off and winding-up of cells. A cell that stops writing new business still needs a controlled process for claims, reserves, contracts, records, service providers, reporting and assets. Stopping underwriting is therefore a change in operating status, not simply a board decision to close the file.

Where a cell’s liabilities cannot be met from the cell’s assets and available recourse is insufficient, Chapter 17 provides for reorganisation or winding-up as if the cell were a Maltese insurance undertaking. That is a material reason not to market a PCC cell as an insolvency-proof compartment.

Governance and Solvency II developments

MFSA amendments published in April 2025 stated that a captive undertaking would not be required to audit its Solvency and Financial Condition Report under the amended Chapter 8 provision. The same material separately identified the need for a provision addressing whether that treatment applies where a PCC cell is a pure captive. Use the operative Chapter 8 text for the relevant undertaking, cell and reporting period rather than treating the circular alone as a blanket exemption.

Directive (EU) 2025/2 recognises the particular risk profile of captive insurers and reinsurers and includes captive-related proportionality measures within the small-and-non-complex framework. As at October 1, 2026, Malta’s implementation work for the Solvency II 2020 Review remained a live national workstream. A launch planned for 2026 or 2027 should therefore refresh its capital, reporting, governance and eligibility assumptions against the Maltese measures in force at that time.

Tax, reporting and residence: what incorporation does not prove

The Malta Tax and Customs Administration states that companies are generally charged at 35% on net chargeable income, and that tax registration can arise from incorporation, management and control in Malta or carrying on activity there. That general framework does not determine the treatment of premiums, technical provisions, reinsurance recoveries, cell income, distributions, refunds or foreign-source income. It also does not prove that a PCC cell is a separate taxpayer or that incorporation creates Maltese tax residence for the wider group.

MTCA also says insurance companies do not use the Tax Index of Financial Data because their financial-reporting requirements are regulated under the Insurance Business Act and they should continue submitting paper financial statements and prescribed attachments. That concerns tax-return reporting and should not be confused with MFSA prudential reporting, statutory accounts or Solvency II returns.

Keeping this article separate from general insurer formation

A general article on starting an insurance company in Malta should cover broader insurer formation, licensing across business classes and the wider authorisation framework. This article is narrower: it addresses affiliated-risk eligibility, the distinction between captive status and legal form, standalone versus cellular architecture, PCC recourse, ICC separation, cell governance, run-off and proportionality. The overlap on authorisation, solvency, outsourcing, reporting and tax registration is unavoidable, but the decision here is whether the captive and cellular model fits the group’s risk and governance needs.

A brief Malta pause

For a moment away from capital models and cell registers, Ġgantija in Xagħra, Gozo offers useful perspective. The Office of the President describes the temples as “a memorial of 8,000 years of Maltese history”. It is a small reminder that Malta’s legal and institutional layers reward careful sequencing rather than shortcut thinking.

Questions people ask

Is a captive the same thing as a PCC or ICC?

No. Captive describes the authorised undertaking’s exclusive group-risk purpose. PCC and ICC describe legal architecture. A captive can operate as a standalone undertaking, a PCC cell or an ICC cell, subject to the applicable rules and approvals.

Does a protected cell have separate legal personality?

No. A protected cell in a Malta PCC has no separate legal identity. The PCC is one legal entity. An incorporated cell in an ICC is different: it is a separate company with separate legal personality.

Can creditors reach a PCC’s core assets?

Generally, cellular creditors claim first against the relevant cell’s assets and may have secondary recourse to core assets once those assets are exhausted. Qualifying affiliated-insurance cells may be able to use a non-recourse provision subject to the applicable own-funds test and transitional rules. The operative regulation and approval documents must be checked.

Can a PCC host unrelated corporate groups?

A PCC can contain multiple cells, but the sources do not establish a blanket permission or prohibition for unrelated groups. The proposed ownership, risk perimeter, business classes, conflicts, governance, segregation and MFSA approval position must be tested for the actual arrangement.

Does an ICC guarantee that the group cannot be reached?

No. Separate legal personality provides entity-level separation, but guarantees, parental support, letters of credit, policy wording, reinsurance and service contracts can create additional obligations.

Is a Malta captive automatically authorised when incorporated?

No. MFSA authorisation and, for a new cell, prior written approval are required. Malta Business Registry incorporation does not itself authorise insurance activity.

What changed for captive cell committee members in July 2026?

With immediate effect, MFSA no longer conducts a fitness-and-properness assessment for every cell committee member of the specified captive and other PCCs; only the chair is subject to the personal questionnaire process. The licence holder remains responsible for due diligence, suitability assessments, records and ongoing monitoring.

Does forming a Malta captive guarantee a tax result?

No. General corporate-tax rules do not determine the treatment of premiums, reserves, reinsurance, cell income, distributions or foreign-source income, and incorporation does not by itself establish a particular tax residence or effective rate.